![ITALIA ECONOMY - PHARMANUTRA S.P.A. LANCIA SUL MERCATO I NUOVI PRODOTTI CETILAR® ORO E APPORTAL® VITAL ITALIA ECONOMY - PHARMANUTRA S.P.A. LANCIA SUL MERCATO I NUOVI PRODOTTI CETILAR® ORO E APPORTAL® VITAL](https://italiaeconomy.it/wp-content/uploads/2022/09/Cetilar-ORO-AW-2022-scaled.jpg.webp)
ITALIA ECONOMY - PHARMANUTRA S.P.A. LANCIA SUL MERCATO I NUOVI PRODOTTI CETILAR® ORO E APPORTAL® VITAL
![Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional supplement Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional supplement](https://www.nutraingredients.com/var/wrbm_gb_food_pharma/storage/images/_aliases/reference/media/images/15-04-fatigue-results-chart/12367396-1-eng-GB/15-04-Fatigue-results-chart.png)
Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional supplement
![Junia Pharma lancia sul mercato il nuovo ApportAL® Vital - Junia Pharma - Salute di bambini e neonati Junia Pharma lancia sul mercato il nuovo ApportAL® Vital - Junia Pharma - Salute di bambini e neonati](https://juniapharma.it/wp-content/uploads/2022/09/junia-pharma-news-lancio-apportal-vital.png)
Junia Pharma lancia sul mercato il nuovo ApportAL® Vital - Junia Pharma - Salute di bambini e neonati
![Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional supplement Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional supplement](https://www.nutraingredients-usa.com/var/wrbm_gb_food_pharma/storage/images/publications/food-beverage-nutrition/nutraingredients-usa.com/news/promotional-features/chronic-covid-syndrome-a-new-study-shows-the-positive-effects-of-using-apportal-a-targeted-nutritional-supplement/12660465-1-eng-GB/Chronic-COVID-syndrome-a-new-study-shows-the-positive-effects-of-using-Apportal-a-targeted-nutritional-supplement.jpg)